Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Holoweckyj, N."'
Autor:
Wildsmith S; AstraZeneca, Cambridge, United Kingdom., Li W; AstraZeneca, Gaithersburg, Maryland., Wu S; AstraZeneca, Gaithersburg, Maryland., Stewart R; AstraZeneca, Cambridge, United Kingdom., Morsli N; AstraZeneca, Cambridge, United Kingdom., Raja R; AstraZeneca, Gaithersburg, Maryland., Zhang Q; AstraZeneca, Gaithersburg, Maryland., Ye J; AstraZeneca, Gaithersburg, Maryland., He P; AstraZeneca, Gaithersburg, Maryland., Shetty J; AstraZeneca, Gaithersburg, Maryland., Yovine A; AstraZeneca, Cambridge, United Kingdom., Holoweckyj N; AstraZeneca, Gaithersburg, Maryland., Real K; AstraZeneca, Cambridge, United Kingdom., Walker J; AstraZeneca, Cambridge, United Kingdom., Wrona M; AstraZeneca, Warsaw, Poland., de Los Reyes M; AstraZeneca, Gaithersburg, Maryland., Barker C; AstraZeneca, Cambridge, United Kingdom., Whiteley J; AstraZeneca, Cambridge, United Kingdom., Haddad R; Dana-Farber Cancer Institute, Boston, Massachusetts., Licitra L; Head & Neck Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano, University of Milan, Milan, Italy., Ferris R; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Fayette J; Centre Léon Bérard, Lyon, France., Zandberg DP; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Siu LL; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Mesía R; Catalan Institute of Oncology, B-ARGO group, IGTP, Badalona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 01; Vol. 29 (11), pp. 2066-2074.
Autor:
Thanabalasuriar A; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; McGill University, Department of Pharmacology and Therapeutics, Faculty of Medicine, Montreal, QC Canada., Chiang AJ; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA., Morehouse C; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Camara M; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hawkins S; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, USA., Keller AE; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Koksal AC; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA., Caceres CS; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Berlin AA; Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Holoweckyj N; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Takahashi VN; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Cheng L; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., de Los Reyes M; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Pelletier M; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Patera AC; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Sellman B; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hess S; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA., Marelli M; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA., Boo CC; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA., Cohen TS; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., DiGiandomenico A; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. antonio.digiandomenico@astrazeneca.com.
Publikováno v:
Science advances [Sci Adv] 2021 Mar 05; Vol. 7 (10). Date of Electronic Publication: 2021 Mar 05 (Print Publication: 2021).
Autor:
Li, Tianyi1 (AUTHOR), Song, Ying2 (AUTHOR), Wei, Lijuan2 (AUTHOR), Song, Xiangyi2 (AUTHOR), Duan, Ruifeng2 (AUTHOR) duanruifeng@jlu.edu.cn
Publikováno v:
Cell Communication & Signaling. 10/14/2024, Vol. 22 Issue 1, p1-22. 22p.
Autor:
Kuziora, M., Si, H., Higgs, B., Brohawn, P., Streicher, K., Jure-Kunkel, M., Raja, R., Helman, E., Franovic, A., Cooper, Z., Shrestha, Y., Holoweckyj, N., Lee, Y., Achour, I., Ye, J., Mukhopadhyay, P., Dennis, P.A., Melillo, G., Abdullah, S.E., Ranade, K.
Publikováno v:
In Annals of Oncology December 2018 29 Supplement 10:x1-x1
Autor:
Papadakos, Stavros P.1 (AUTHOR) stpap@med.uoa.gr, Chatzikalil, Elena1 (AUTHOR) elenachatz@med.uoa.gr, Vakadaris, Georgios2,3 (AUTHOR) vakadarisgeorgios@gmail.com, Reppas, Lampros4 (AUTHOR) lreppas@med.uoa.gr, Arvanitakis, Konstantinos2,3 (AUTHOR) arvanitak@auth.gr, Koufakis, Theocharis5 (AUTHOR) thkoyfak@hotmail.com, Siakavellas, Spyros I.6 (AUTHOR) s.siakavellas@gmail.com, Manolakopoulos, Spilios6 (AUTHOR) smanolak@med.uoa.gr, Germanidis, Georgios2,3 (AUTHOR) geogerm@auth.gr, Theocharis, Stamatios1 (AUTHOR) geogerm@auth.gr
Publikováno v:
Cancers. Jul2024, Vol. 16 Issue 14, p2609. 26p.
Autor:
Zhong H; Oncology Research, MedImmune, Gaithersburg, Maryland. zhongh@medimmune.com ticed@medimmune.com., Chen C; Oncology Research, MedImmune, Gaithersburg, Maryland., Tammali R; Oncology Research, MedImmune, Gaithersburg, Maryland., Breen S; Oncology Research, MedImmune, Gaithersburg, Maryland., Zhang J; Oncology Research, MedImmune, Gaithersburg, Maryland., Fazenbaker C; Oncology Research, MedImmune, Gaithersburg, Maryland., Kennedy M; Oncology Research, MedImmune, Gaithersburg, Maryland., Conway J; Oncology Research, MedImmune, Gaithersburg, Maryland., Higgs BW; Oncology Research, MedImmune, Gaithersburg, Maryland., Holoweckyj N; Oncology Research, MedImmune, Gaithersburg, Maryland., Raja R; Oncology Research, MedImmune, Gaithersburg, Maryland., Harper J; Oncology Research, MedImmune, Gaithersburg, Maryland., Pierce AJ; Translational Science - Oncology, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom., Herbst R; Oncology Research, MedImmune, Gaithersburg, Maryland., Tice DA; Oncology Research, MedImmune, Gaithersburg, Maryland. zhongh@medimmune.com ticed@medimmune.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2019 Jan; Vol. 18 (1), pp. 89-99. Date of Electronic Publication: 2018 Oct 23.
Autor:
Wang S; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Wang J; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Kumar V; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Karnell JL; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA.; Viela Bio, Gaithersburg, MD, 20878, USA., Naiman B; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Gross PS; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Rahman S; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Zerrouki K; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Hanna R; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Morehouse C; Translational Medicine, MedImmune LLC, Gaithersburg, MD, 20878, USA., Holoweckyj N; Translational Medicine, MedImmune LLC, Gaithersburg, MD, 20878, USA., Liu H; Translational Medicine, MedImmune LLC, Gaithersburg, MD, 20878, USA., Manna Z; The Office of Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Goldbach-Mansky R; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Hasni S; The Office of Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Siegel R; The Office of Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Sanjuan M; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA.; Bristol-Myers Squibb, Princeton, NJ, 08543, USA., Streicher K; Translational Medicine, MedImmune LLC, Gaithersburg, MD, 20878, USA., Cancro MP; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Kolbeck R; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA., Ettinger R; Respiratory, Inflammation, and Autoimmunity Group, MedImmune LLC, Gaithersburg, MD, 20878, USA. ettingerr@vielabio.com.; Viela Bio, Gaithersburg, MD, 20878, USA. ettingerr@vielabio.com.
Publikováno v:
Nature communications [Nat Commun] 2018 May 01; Vol. 9 (1), pp. 1758. Date of Electronic Publication: 2018 May 01.
Autor:
Wiseman J; Discovery Science, Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Mölndal, Sweden. John.w.wiseman@astrazeneca.com., Gregersson P; Institute for Biomedicine, Gothenburg University, Gothenburg, Sweden., Johansson J; Discovery Science, Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Mölndal, Sweden., Magnell K; Discovery Science, Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Mölndal, Sweden., Pilataxi F; Department of Translational Sciences, MedImmune, Gaithersburg, MD, USA., Morehouse C; Department of Translational Sciences, MedImmune, Gaithersburg, MD, USA., Brohawn P; Department of Translational Sciences, MedImmune, Gaithersburg, MD, USA., Holoweckyj N; Department of Translational Sciences, MedImmune, Gaithersburg, MD, USA., Strout P; Department of Oncology Research, MedImmune, Gaithersburg, MD, USA., Cho S; Department of Oncology Research, MedImmune, Gaithersburg, MD, USA.
Publikováno v:
Transgenic research [Transgenic Res] 2017 Dec; Vol. 26 (6), pp. 791-798. Date of Electronic Publication: 2017 Aug 17.
Autor:
Ullas, Sumana1 (AUTHOR) sullas@flagshippioneering.com, Sinclair, Charles1 (AUTHOR) csinclair@flagshippioneering.com
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3851. 19p.
Autor:
Leyland R; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Watkins A; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Mulgrew KA; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Holoweckyj N; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Bamber L; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Tigue NJ; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Offer E; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Andrews J; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Yan L; MedImmune LLC, Mountain View, California., Mullins S; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Oberst MD; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Coates Ulrichsen J; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Leinster DA; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., McGlinchey K; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Young L; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Morrow M; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Hammond SA; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Mallinder P; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Herath A; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Leow CC; MedImmune LLC, One MedImmune Way, Gaithersburg, Maryland., Wilkinson RW; MedImmune Ltd., Granta Park, Cambridge, United Kingdom. wilkinsonr@medimmune.com., Stewart R; MedImmune Ltd., Granta Park, Cambridge, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jul 01; Vol. 23 (13), pp. 3416-3427. Date of Electronic Publication: 2017 Jan 09.